IP Library Granted Patent US 10,006,009
Granted Patent B2
US 10,006,009 · App. 15/291,367 · Granted Jun 26, 2018

Codon-optimized gene for mutated shrimp luciferase and method for use thereof

Inventors: Satoshi Inouye (Yokohama, JP); Junichi Sato (Yokohama, JP)
Assignee: JNC CORPORATION
C12N9/0069C12N9/0006C12Q1/66C12Y113/12013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,006,009
App. No.
15/291,367
Granted
Jun 26, 2018
Kind
B2
Abstract

There has been a demand for a codon-optimized gene for the mutated catalytic domain of Oplophorus luciferase, which is capable of efficiently expressing a protein both in a cultured animal cell and Escherichia coli . There has also been a demand for a substrate coelenterazine analog showing a higher activity than that of native 19 kDa protein. The invention provides a polynucleotide comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2. According to the invention, bis-coelenterazine is used as a substrate coelenterazine analog suitable for the photoprotein encoded by the polynucleotide comprising the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2.

Claims (12)

1. A kit comprising:

(i) a protein selected from the group consisting of (a) and (b) below:

(a) a protein comprising the amino acid sequence of SEQ ID NO: 1; and

(b) a protein comprising the amino acid sequence of SEQ ID NO: 1 substituted at 1 to 8 positions, none of which includes any one of the positions 6, 13, 20, 29, 35, 45, 46, 56, 70, 74, 77, 92, 117, 126, 140, and 168, and wherein the protein has a higher luminescent catalyst activity than that of the native 19 kDa protein of Oplophorus luciferase by using bis-coelenterazine or h-coelenterazine as a substrate in a luminescence reaction; and,

(ii) bis-coelenterazine or h-coelenterazine.

2. The kit according to claim 1 , wherein the protein is

encoded by a polynucleotide

comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2.

3. The kit according to claim 2 , wherein the polynucleotide further comprises a polynucleotide encoding a polypeptide consisting of an amino acid sequence for promoting translation and/or a polynucleotide encoding a polypeptide consisting of an amino acid sequence for purification.

4. The kit according to claim 2 , wherein the polynucleotide consists of any one of the nucleotide sequences of SEQ ID NO: 5, SEQ ID NO: 8, and SEQ ID NO: 10.

5. The kit according to claim 1 , wherein the protein comprises the amino acid sequence of SEQ ID NO: 1.

6. The kit according to claim 1 , wherein the protein comprises a polypeptide consisting of any one of the amino acid sequences of SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, and SEQ ID NO: 16.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: JNC CORPORATION
To: PROLUME LTD.
Reel/Frame 063962/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2016
From: INOUYE, SATOSHI; SATO, JUNICHI
To: JNC CORPORATION
Reel/Frame 039997/0302 →
Priority Claims (1)
JP 2013-038350 · Feb 28, 2013 · national
Continuity (4)
Division 15191730 · Jun 24, 2016
Division 15067591 · Mar 11, 2016
Division 14188838 · Feb 25, 2014
Related Publication 20170029789A1 · Feb 2, 2017